Primus Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPrimus Pharmaceuticals

Primus Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Impoyz	Clobetasol	2017-11-28	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses
Metaxalone	Metaxalone	2015-06-01	2026	Myositis , Pain , Muscle spasticity , Muscle cramp , Spasm , Muscle rigidity
Sernivo	Betamethasone	2016-02-05	2027-2039	Psoriasis , Atopic dermatitis , Pruritus ani , Inflammation , Facial dermatoses , Seborrheic dermatitis , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Mycoses , Oral candidiasis , Vulvovaginal candidiasis , Tinea pedis , Cutaneous candidiasis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

postoperative pain

,

,

postoperative complications

,

spinal diseases

,

spinal stenosis

,

,

,

cognitive dysfunction

,

,

healthy volunteers/patients

,

knee osteoarthritis

,

,

,

colonic diseases

,

functional colonic diseases

,

healthy volunteers/patients

Clobetasol propionate

healthy volunteers/patients

Betamethasone dipropionate

hyperlipidemias

,

hyperlipoproteinemias

healthy volunteers/patients

,

coronavirus infections

,

therapeutic equivalency

,

,

metabolic syndrome

,

,

,

insulin resistance

,

,

,

,

,

,

,

,

,

,

,

,

,

,

,

muscle weakness

,

,

,

,

non-alcoholic fatty liver disease

,

alcoholic fatty liver

,

metabolic bone diseases

,

,

,

breast neoplasms

,

cardiovascular diseases

,

,

rheumatoid arthritis

,

heart disease risk factors

,

,

drug-related side effects and adverse reactions

,

ulcerative colitis

,

peripheral nervous system diseases

,

venous insufficiency

,

,

,

,

,

venous thrombosis

,

postthrombotic syndrome

,

,

polycystic ovary syndrome

,

,

,

,

body weight changes

,

,

exercise tolerance

,

cognitive dysfunction

,

,

,

,

type 2 diabetes mellitus

,

,

acid-base imbalance

,

psychological power

,

oxidative stress

,

,

telerehabilitation

,

pelvic floor disorders

,

,

,

,

postmenopausal osteoporosis

,

,

,

biological availability

,

prediabetic state

,

diabetic neuropathies

,

,

congenital abnormalities

,

vascular malformations

,

,

systemic scleroderma

,

diffuse scleroderma

,

ovarian hyperstimulation syndrome

,

vascular diseases

,

obstructive sleep apnea

,

,

,

,

dental pulp exposure

,

dental pulp capping

,

,

blood circulation

,

replacement arthroplasty knee

,

,

hematologic neoplasms

,

,

,

,

metabolic bone diseases

,

colorectal neoplasms

,

,

squamous cell carcinoma of head and neck

,

biliary tract neoplasms

diabetes mellitus

,

type 1 diabetes mellitus

,

insulin resistance

,

type 2 diabetes mellitus

,

,

,

,

,

bacterial infections

,

atrial fibrillation

,

,

pancreatic neoplasms

,

,

respiratory tract infections

,

,

,

,

,

,

,

type 2 diabetes mellitus

Bos taurus adrenal cortex corticosteroids

macular degeneration

,

multiple myeloma

,

plasma cell neoplasms

,

systemic lupus erythematosus

,

castleman disease

,

,

geographic atrophy

,

prostatic neoplasms

,

graft vs host disease

,

bronchiolitis obliterans syndrome

,

castration-resistant prostatic neoplasms

,

breast neoplasms

,

duchenne muscular dystrophy

,

muscular dystrophies

,

knee osteoarthritis

diabetes mellitus

,

type 1 diabetes mellitus

,

type 2 diabetes mellitus

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use